Bectas Therapeutics, Inc.

Biotechnology company · Houston, Texas, United States

Bectas Therapeutics, Inc. is a biotechnology company headquartered in Houston, Texas, United States. Its earliest recorded incorporation is in 2022. It has reported private securities offerings to the US SEC, most recently $5.5 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Bectas Therapeutics at a glance

Typebiotechnology company

HeadquartersHouston, Texas, United States

Earliest incorporation on record2022

SEC CIK2038826

What does Bectas Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $5.5 million sold (2025).

Frequently asked questions about Bectas Therapeutics

Where is Bectas Therapeutics headquartered?

Bectas Therapeutics, Inc. is headquartered in Houston, Texas, United States.

What does Bectas Therapeutics do?

Bectas Therapeutics, Inc. is a biotechnology company.

When was Bectas Therapeutics founded?

The earliest incorporation on record for Bectas Therapeutics, Inc. is in 2022, according to public company registers.

Similar companies

Pulmotect, Inc.Houston, Texas, United States
Kiromic Biopharma, Inc.Houston, Texas, United States
March Biosciences, Inc.Houston, Texas, United States
Autoimmunity Biologic Solutions Inc.Houston, Texas, United States
Fannin Partners, LLCHouston, Texas, United States
Brevitest Technologies, Inc.Houston, Texas, United States
Pupil Bio, Inc.Houston, Texas, United States
Asylia Therapeutics, Inc.Houston, Texas, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences